Free shipping on all orders over $ 500

p38 MAPK-IN-1

Cat. No. M14178

All AbMole products are for research use only, cannot be used for human consumption.

p38 MAPK-IN-1 Structure
Size Price Availability
2mg USD 300  USD300 4-7 Days
5mg USD 420  USD420 4-7 Days
10mg USD 600  USD600 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM. p38 MAPK-IN-1 shows sustained levels, low clearance and good bioavailability.

Chemical Information
Molecular Weight 349.35
CAS Number 1006378-90-0
Solubility (25°C) DMSO 8.33 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Joseph M Grimes, et al. p38 MAPK inhibition: A promising therapeutic approach for COVID-19

[2] Ana Cuadrado, et al. Mechanisms and functions of p38 MAPK signalling

[3] Hae-Young Yong, et al. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

[4] Lydia R Coulthard, et al. p38(MAPK): stress responses from molecular mechanisms to therapeutics

[5] Tyler Zarubin, et al. Activation and signaling of the p38 MAP kinase pathway

Related p38 MAPK Products
SSK1

SSK1 is a senescence-specific killing compound and is a precursor for β-galactosidase, which can reduce the inflammatory response. SSK1 can activate the phosphorylation of p38 MAPK and MKK3/MKK6 in senescent cells, promote mitochondrial DNA damage and selectively killed senescent cells.

p38 MAP Kinase Inhibitor III

p38 MAP Kinase Inhibitor III is a p38 MAPK inhibitor with an IC50 of 0.9 μM. p38 MAP Kinase Inhibitor III also inhibits IL-1β and TNF-α release with IC50 values of 0.37 μM and 0.044 μM, respectively.

(R)-STU104 

(R)-STU104 is a potent and orally active TAK1-MKK3 interaction inhibitor with IC50s of 0.58 μM and 4.0 μM for TNF-α and MKK3 phosphorylation.

SB 706504 

SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides-stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD).

RWJ-67657

RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor with IC50s of 1 and 11 μM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: p38 MAPK-IN-1 supplier, p38 MAPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.